tyrosine has been researched along with glucagon-like peptide 1 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Eng, J; Raufman, JP; Singh, G | 1 |
| Egan, JM; Janczewski, AM; Montrose-Rafizadeh, C; Pineyro, MA; Sollott, SJ; Wang, Y; Zhou, J | 1 |
| Bungo, T; Furuse, M; Hasegawa, S; Masuda, Y; Saito, N; Shimojo, M; Sugahara, K | 1 |
| Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP | 1 |
| Abidi, F; Donnelly, D; Findlay, JB; López de Maturana, R; Treece-Birch, J | 1 |
| Ballaron, SJ; Basha, F; Fry, EH; Jakob, CG; Lin, CW; Longenecker, KL; Lubben, TH; Madar, DJ; Pei, Z; Pireh, D; Stashko, MA; Stewart, KD; Stoll, VS; Trevillyan, JM; von Geldern, TW; Wiedeman, PE; Wilk, S; Yong, H | 1 |
| Bonfigli, AR; Ceriello, A; Esposito, K; Giugliano, D; Marra, M; Testa, R | 1 |
| Bucciarelli, L; Canivell, S; Ceriello, A; Genovese, S; La Sala, L; Novials, A; Ortega, E; Pujadas, G; Rondinelli, M | 1 |
| Barba, J; Beaumont, J; Coma-Canella, I; Díez, J; González, A; Huerta, A; López, B; Ravassa, S | 1 |
| Louie, JCY; Sit, WH; Tse, IMY; Wan, JMF; Wong, THT | 1 |
| Beglinger, C; Bordier, V; Budzinska, A; Hartmann, B; Holst, JJ; Meyer-Gerspach, AC; Rehfeld, JF; Teysseire, F; Van Oudenhove, L; Weltens, N; Wölnerhanssen, BK | 1 |
| Alcocer, B; Ariyarathenam, AV; Berrisford, RG; Chan, D; Forbes, R; Humphreys, ML; Lewis, SJ; Pournaras, DJ; Sanders, G; Tham, JC; Wheatley, TJ | 1 |
| Chepurny, OG; Collier, JJ; Cooney, RN; Holz, GG; Leech, CA; Meng, Q; Molnar, ME; Pruekprasert, N | 1 |
| Andersson, O; Charbord, J; Chu, L; Dirice, E; Kulkarni, RN; Liu, KC; Mattsson, CL; Miskelly, MG; Teinturier, R; Terasaki, M; Wierup, N; Zhou, Q | 1 |
| Chu, N; Jie, H; Leung, K; Ling, J; Poon, E | 1 |
| Bornath, DPD; Hazell, TJ; Jarosz, C; Kenno, KA; McCarthy, SF; Medeiros, PJ; Tucker, JAL | 1 |
1 review(s) available for tyrosine and glucagon-like peptide 1
| Article | Year |
|---|---|
The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes.
Topics: Acarbose; Anti-Inflammatory Agents; Bacteria; Bile Acids and Salts; Diabetes Mellitus, Type 2; Fatty Acids, Volatile; Glucagon-Like Peptide 1; Humans; Lactulose; Laxatives; Lipopolysaccharides; Peptides; Tyrosine | 2022 |
4 trial(s) available for tyrosine and glucagon-like peptide 1
| Article | Year |
|---|---|
The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an "endothelial resistance" to glucagon-like peptide 1 in diabetes.
Topics: Diabetes Mellitus; Endothelium, Vascular; Female; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Male; Middle Aged; Tyrosine; Vasodilation | 2011 |
Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes.
Topics: Adult; Antioxidants; Ascorbic Acid; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Dinoprost; Female; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inflammation; Inflammation Mediators; Infusions, Parenteral; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Oxidative Stress; Reperfusion Injury; Time Factors; Treatment Outcome; Tyrosine; Vasodilation; Young Adult | 2013 |
Consuming decaffeinated coffee with milk and sugar added before a high-glycaemic index meal improves postprandial glycaemic and insulinaemic responses in healthy adults.
Topics: Adult; Animals; Blood Glucose; Caffeine; Coffee; Cross-Over Studies; Dietary Sugars; Drinking; Female; Glucagon-Like Peptide 1; Glycemic Index; Healthy Volunteers; Humans; Insulin; Male; Meals; Middle Aged; Milk; Postprandial Period; Tyrosine; Young Adult | 2020 |
The Role of D-allulose and Erythritol on the Activity of the Gut Sweet Taste Receptor and Gastrointestinal Satiation Hormone Release in Humans: A Randomized, Controlled Trial.
Topics: Cholecystokinin; Cross-Over Studies; Erythritol; Female; Fructose; Gastrointestinal Hormones; Glucagon-Like Peptide 1; Humans; Male; Peptide YY; Satiation; Taste; Tyrosine; Water | 2022 |
11 other study(ies) available for tyrosine and glucagon-like peptide 1
| Article | Year |
|---|---|
Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig.
Topics: Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Cyclic AMP; Exenatide; Gastric Mucosa; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Guinea Pigs; Iodine Radioisotopes; Male; Molecular Sequence Data; Pancreas; Peptides; Receptors, Gastrointestinal Hormone; Structure-Activity Relationship; Tyrosine; Venoms | 1994 |
Glucagon-like peptide-1 does not mediate amylase release from AR42J cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amylases; Animals; Base Sequence; Calcium Signaling; Cell Line; Cholecystokinin; Cyclic AMP; DNA Primers; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Pancreas; Peptide Fragments; Phosphorylation; Protein Precursors; Rats; Receptors, Glucagon; Reverse Transcriptase Polymerase Chain Reaction; Tyrosine | 1999 |
Effects of substitution of N-terminal amino acid of glucagon-like peptide-1 (7-36) amide on food intake of the neonatal chick.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Animals, Newborn; Chickens; Eating; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Histidine; Injections, Intraventricular; Male; Molecular Sequence Data; Peptide Fragments; Protein Precursors; Structure-Activity Relationship; Tyrosine | 1999 |
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Topics: Adenosine Deaminase; Amino Acid Substitution; Animals; Binding, Competitive; Blood Glucose; Cell Line, Tumor; Cricetinae; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fibroblasts; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutamine; Glycoproteins; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Peptide Fragments; Phenylalanine; Proline; Protein Precursors; Rats; Receptors, Glucagon; Spectrometry, Mass, Electrospray Ionization; Transformation, Genetic; Tyrosine | 2003 |
Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues.
Topics: Amino Acid Sequence; Animals; Cell Line; Cyclic AMP; Exenatide; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Inhibitory Concentration 50; Ligands; Methionine; Molecular Sequence Data; Peptide Fragments; Peptides; Protein Precursors; Rats; Receptors, Glucagon; Sequence Alignment; Sequence Deletion; Tyrosine; Venoms | 2004 |
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.
Topics: Animals; Binding Sites; Crystallization; Dimerization; Dipeptidases; Dipeptidyl Peptidase 4; Glucagon-Like Peptide 1; Humans; Kidney; Kinetics; Models, Molecular; Molecular Structure; Protein Conformation; Rats; Recombinant Proteins; Structure-Activity Relationship; Tyrosine; X-Ray Diffraction | 2006 |
Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: a pilot study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Animals; Antioxidants; Atrial Remodeling; Cardiomegaly; Cardiovascular System; Case-Control Studies; Cell Line; Deoxyguanosine; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Female; Glucagon-Like Peptide 1; Humans; Male; Mice; Middle Aged; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Palmitic Acid; Pilot Projects; Retrospective Studies; Tyrosine; Ventricular Remodeling | 2015 |
Gut hormones profile after an Ivor Lewis gastro-esophagectomy and its relationship to delayed gastric emptying.
Topics: Esophageal Neoplasms; Esophagectomy; Gastric Emptying; Gastroparesis; Glucagon-Like Peptide 1; Humans; Peptides; Postoperative Complications; Retrospective Studies; Tyrosine | 2022 |
The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db/db mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Nicotinic Agonists; Pyridines; Sitagliptin Phosphate; Tyrosine | 2022 |
In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Discovery; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucose; Incretins; Mice; Tyrosine; Zebrafish | 2022 |
Intense interval exercise induces lactate accumulation and a greater suppression of acylated ghrelin compared with submaximal exercise in middle-aged adults.
Topics: Adult; Appetite; Energy Intake; Ghrelin; Glucagon-Like Peptide 1; Humans; Lactic Acid; Middle Aged; Peptide YY; Tyrosine; Young Adult | 2023 |